Patrick Bourdet, founder and former CEO of AREVA Med (Orano Med), joins the Radio Pharma Logistics Group (RLG). After being a consultant for its three companies, Patrick Bourdet is now a shareholder of the RLG.
In 2017, more than 11 million patients received their care thanks to the actions of the Radio Pharma Logistics Group.
Philippe Sueur, President of Isovital said: “We are very pleased that Patrick is joining RLG’s capital to significantly strengthen our Executive Committee. Patrick will bring us his international business experience, his knowledge of large groups and his global vision of the radiopharmaceutical market. He will concretely participate in the development of the Radio Pharma Logistics Group for the coming years.”
Patrick Bourdet added “I am satisfied to join RLG and its companies, highly specialized in radiopharmaceutical logistics operations. In 2017, more than 11 million patients received their care thanks to the actions of the RLG companies and I look forward to being associated with the ISOvital, ISOlife and Isotopes Service International teams, which play an essential role in the life of patients”.
About:
Radio Pharma Logistics Group (RLG) consists in the following companies: Isovital, Isolife and Isotopes Service International (ISI). The companies of the RLG group are specialized in the transport of radiopharmaceuticals and sensitive materials for national and international companies. Since their foundation in 2005, Isovital and Isolife have had a constant and remarkable evolution. At the end of 2017, RLG expanded with the acquisition of Isotope Service International, in Belgium (ISI). In 2017, more than 11 million patients received their care thanks to the actions of the RLG company.
www.radiopharmalogistics.com
www.isovital.fr
www.isolife.fr
www.isotopes.be

It allows you to discover the world of ISI and all our services.
Specialists in “Just in time the same day and the next day” deliveries, we invite you to learn more about our company, our services as well as our certifications and conformity.
Please do not hesitate to contact us for more information.